Cargando…

Early Vascular Alterations in SLE and RA Patients—A Step towards Understanding the Associated Cardiovascular Risk

Accelerated atherosclerosis represents a major problem in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients, and endothelial damage is a key feature of atherogenesis. We aimed to assess early endothelial changes in SLE and RA female patients (127 SLE and 107 RA) without...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Maria José, Carmona-Fernandes, Diana, Canhão, Helena, Canas da Silva, José, Fonseca, João Eurico, Gil, Victor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3433444/ https://www.ncbi.nlm.nih.gov/pubmed/22962622 http://dx.doi.org/10.1371/journal.pone.0044668

Ejemplares similares

Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile
por: Carmona-Fernandes, Diana, et al.
Publicado: (2013)

Soluble receptor activator of nuclear factor κB ligand/osteoprotegerin ratio is increased in systemic lupus erythematosus patients
por: Carmona-Fernandes, Diana, et al.
Publicado: (2011)

Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?
por: Romão, Vasco Crispim, et al.
Publicado: (2013)

TRAF1/C5 locus is associated with response to anti-TNF in rheumatoid arthritis
por: Canhão, Helena, et al.
Publicado: (2012)

Response measures influence comparative effectiveness of biological drugs in rheumatoid arthritis
por: Canhao, Helena, et al.
Publicado: (2012)

Challenges in understanding the role of pregnancy morbidity in cardiovascular risk in SLE
por: Simard, Julia F, et al.
Publicado: (2014)

The Role of Long Non-coding RNAs in the Pathogenesis of RA, SLE, and SS
por: Gao, Yunzhen, et al.
Publicado: (2018)

Influenza Vaccination of Patients With Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA)
por: Stojanovich, Ljudmila
Publicado: (2006)

Contrasting genetic association of IL2RA with SLE and ANCA – associated vasculitis
por: Carr, Edward J, et al.
Publicado: (2009)

HBsAb and HBcAb Have No Significant Effect on the Progression of SLE and RA
por: WANG, Fen, et al.
Publicado: (2017)

Association of IL10RA, IL10RB, and IL22RA Polymorphisms/Haplotypes with Susceptibility to and Clinical Manifestations of SLE
por: Grk, Milka, et al.
Publicado: (2023)

Hydroxychloroquine use is not associated with QTc length in a large cohort of SLE and RA patients
por: Park, Elizabeth, et al.
Publicado: (2021)

Hydroxychloroquine Use Is Not Associated With QTc Length in a Large Cohort of SLE and RA Patients
por: Park, Elizabeth, et al.
Publicado: (2021)

A DNA-Methylated Sight on Autoimmune Inflammation Network across RA, pSS, and SLE
por: Wang, Xingqiang, et al.
Publicado: (2018)

Cross-Disease Innate Gene Signature: Emerging Diversity and Abundance in RA Comparing to SLE and SSc
por: Petrackova, Anna, et al.
Publicado: (2019)

The Serum Cell-Free microRNA Expression Profile in MCTD, SLE, SSc, and RA Patients
por: Stypinska, Barbara, et al.
Publicado: (2020)

Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors
por: Haque, Sahena, et al.
Publicado: (2018)

Arthritis Induces Early Bone High Turnover, Structural Degradation and Mechanical Weakness
por: Vidal, Bruno, et al.
Publicado: (2015)

Correction: Arthritis Induces Early Bone High Turnover, Structural Degradation and Mechanical Weakness
por: Vidal, Bruno, et al.
Publicado: (2015)

Characterization of RA33 (hnRNP-A2/B1)-autoreactive T cells in SLE-patients
por: Fritsch, R, et al.
Publicado: (2001)

Latent autoimmunity across disease-specific boundaries in at-risk first-degree relatives of SLE and RA patients
por: James, Judith A., et al.
Publicado: (2019)

Proteomic Data Analysis for Differential Profiling of the Autoimmune Diseases SLE, RA, SS, and ANCA-Associated Vasculitis
por: Ohlsson, Mattias, et al.
Publicado: (2020)

Relationship between natural and infection‐induced antibodies in systemic autoimmune diseases (SAD): SLE, SSc and RA
por: Böröcz, K., et al.
Publicado: (2020)

Comparative Analysis on Abnormal Methylome of Differentially Expressed Genes and Disease Pathways in the Immune Cells of RA and SLE
por: Fang, Qinghua, et al.
Publicado: (2021)

Atherosclerosis and Bone Loss in Humans–Results From Deceased Donors and From Patients Submitted to Carotid Endarterectomy
por: Carmona-Fernandes, Diana, et al.
Publicado: (2021)

Kynurenine pathway is altered in patients with SLE and associated with severe fatigue
por: Åkesson, Karolina, et al.
Publicado: (2018)

Editorial: Mechanisms by Which SLE-Associated Genetic Variants Contribute to SLE Pathogenesis
por: Crispín, José C., et al.
Publicado: (2019)

PROMISSE: progress in understanding pregnancy complications in patients with SLE
por: Salmon, JE
Publicado: (2012)

From patients with arthralgia, pre-RA and recently diagnosed RA: what is the current status of understanding RA pathogenesis?
por: Molendijk, Marlieke, et al.
Publicado: (2018)

TRAF1/C5 but Not PTPRC Variants Are Potential Predictors of Rheumatoid Arthritis Response to Anti-Tumor Necrosis Factor Therapy
por: Canhão, Helena, et al.
Publicado: (2015)

Worse cardiovascular and renal outcome in male SLE patients
por: Mihailovic, Jelena, et al.
Publicado: (2023)

Methotrexate and low-dose prednisolone downregulate osteoclast function by decreasing receptor activator of nuclear factor-κβ expression in monocytes from patients with early rheumatoid arthritis
por: Perpétuo, Inês Pedro, et al.
Publicado: (2017)

Revisiting the cardiovascular risk of hydroxychloroquine in RA
por: Pers, Yves-Marie, et al.
Publicado: (2020)

Perioperative medical management for patients with RA, SPA, and SLE undergoing total hip and total knee replacement: a narrative review
por: Goodman, Susan M., et al.
Publicado: (2018)

Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE
por: Nived, Ola, et al.
Publicado: (2020)

Cardiovascular risk factor management in patients with RA compared to matched non-RA patients
por: Alemao, Evo, et al.
Publicado: (2016)

Off-label use of biological agents in the management of uveitis: experience from a pediatric rheumatology centre
por: Campanilho-Marques, Raquel, et al.
Publicado: (2011)

NICE guidance for moderate RA—a step in the right direction
por: The Lancet Rheumatology
Publicado: (2021)

B cell alterations during BAFF inhibition with belimumab in SLE
por: Ramsköld, Daniel, et al.
Publicado: (2018)

SLE and APS
por: Avcin, Tadej
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cakcg353skig1i3f1qkevcvjdf